Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study

Drug and Alcohol Dependence

Volumn 147, Issue , 2015, Pages 144-150

  Degenhardt, Louisa ^a,b   Lintzeris, Nicholas ^c,d   Campbell, Gabrielle ^a   Bruno, Raimondo ^a,e   Cohen, Milton ^f   Farrell, Michael ^a   Hall, Wayne D ^g,h  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^e UNIVERSITY OF TASMANIA   (Australia)

^f ST VINCENT'S CLINIC   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Australia; Cannabis; Chronic pain; Medical cannabis use; Pharmaceutical opioids

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CANNABIS; NEUROLEPTIC AGENT; OPIATE; CANNABINOID; MEDICAL CANNABIS; NARCOTIC ANALGESIC AGENT;

ADULT; ALCOHOL USE DISORDER; ANALGESIA; ARTHRITIS; ARTICLE; AUSTRALIA; AUSTRALIAN; CANCER PAIN; CANNABIS ADDICTION; CANNABIS USE; CHRONIC NON CANCER PAIN; CHRONIC PAIN; COHORT ANALYSIS; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; COPING BEHAVIOR; CORRELATION ANALYSIS; DEPRESSION; DRUG DEPENDENCE; EMPLOYMENT STATUS; FEMALE; FIBROMYALGIA; GENERALIZED ANXIETY DISORDER; HEADACHE; HEROIN DEPENDENCE; HUMAN; ICD-10; INCOME; MAJOR CLINICAL STUDY; MALE; PAIN; PAIN SEVERITY; PRESCRIPTION; PREVALENCE; RECREATION; RHEUMATIC DISEASE; SELF CONCEPT; SHINGLE RELATED PAIN; TOBACCO USE; VISCERAL PAIN; MIDDLE AGED; NEOPLASM; TREATMENT OUTCOME;

CANNABIS;

ADULT; ANALGESICS, OPIOID; AUSTRALIA; CANNABINOIDS; CANNABIS; CHRONIC PAIN; COHORT STUDIES; FEMALE; HUMANS; MALE; MEDICAL MARIJUANA; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME;

EID: 84921023363     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.11.031     Document Type: Article

References (32)

1. Australian Institute of Health and Welfare National Drug Strategy Household Survey 2010 - Detailed Findings 2011, Australian Institute of Health and Welfare, Canberra.
2. Beubler E., Jaksch W., Devulder J., Le Poloin B., Bo Honsen O., Meynadier J., Muller-Schwefe G., Zenz M., Mac Sullivan R., O'Brien T., Eisenberg E., Mercodante S., Ventafriddo V., Varrossi G., Vielvoye-Kerkmeer A., Zylicz B., Breivik H., Krajnik M., Lopez J.C., Puig M., Rhodin A., Borgeat A., Collett B., Hanna M., Hunt T., Simpson K. The white paper on opioids and pain: a pan-European challenge: the European white paper on the use of opioids in chronic pain management. J. Pain Palliat. Care Pharmacother. 2006, 20:79-87.
3. Bloodworth D. Issues in opioid management. Am. J. Phys. Med. Rehabil. 2005, 84:S42-S55.
4. Bostwick J.M. The use of cannabis for management of chronic pain. Gen. Hosp. Psychiatry 2014, 36:2-3.
5. Campbell G., Nielsen S., Bruno R., Lintzeris N., Cohen M., Hall W., Larance B., Mattick R.P., Degenhardt L. The Pain and Opioids IN Treatment (POINT) study: characteristics of a cohort using opioids to manage chronic non-cancer pain. Pain 2014, 10.1016/j.pain.0000000000000031.
6. Campbell G., Nielsen R., Bruno R., Larance B., Nielsen S., Cohen M., Lintzeris N., Shand F., Hall W., Hoban B., Kehler C., Farrell M., Degenhardt L. Cohort protocol: the Pain and Opioids IN Treatment (POINT) study. BMC Pharmacol. Toxicol. 2014, 15. 10.1186/2050-6511-1115-1117.
7. Chan D. So why ask me? Are self-report data really that bad?. Statistical and Methodological Myths and Urban Legends: Doctrine, Verity and Fable in the Organizational and Social Sciences 2009, 309-336. Taylor & Francis, New York. C.E. Lance, R.J. Vandenberg (Eds.).
8. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998, 51:253-263.
9. Dworkin R.H., Turk D.C., Farrar J.T., Haythornthwaite J.A., Jensen M.P., Katz N.P., Kerns R.D., Stucki G., Allen R.R., Bellamy N., Carr D.B., Chandler J., Cowan P., Dionne R., Galer B.S., Hertz S., Jadad A.R., Kramer L.D., Manning D.C., Martin S., McCormick C.G., McDermott M.P., McGrath P., Quessy S., Rappaport B.A., Robbins W., Robinson J.P., Rothman M., Royal M.A., Simon L., Stauffer J.W., Stein W., Tollett J., Wernicke J., Witter J. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005, 113:9-19.
10. Farrell M., Buchbinder R., Hall W. Should doctors prescribe cannabinoids?. BMJ 2014, 348:g2737.
11. Hazekamp A., Heerdink E.R. The prevalence and incidence of medicinal cannabis on prescription in The Netherlands. Eur. J. Clin. Pharmacol. 2013, 69:1575-1580.
12. Kessler R.C., Ustun T.B. The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int. J. Methods Psychiatr. Res. 2004, 13:93-121.
13. Kroenke K., Spitzer R., Williams J.B.W. The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 2001, 16:606-613.
14. Kroenke K., Spitzer R.L., Williams J.B.W., Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen. Hosp. Psychiatry 2010, 32:345-359.
15. Larance, B., Bruno, R., Lintzeris, N., Black, E., Degenhardt, L., Brown, A., Nielsen, S., Dunlop, A., Holland, R., Cohen, M., Mattick, R.P., (under review). Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale. Pain.
16. Lucas P. Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice. Int. J. Drug Policy 2009, 20:296-303.
17. Mattick R.P., Larance B., Bruno R., Black E., Lintzeris N., Degenhardt L., Nielsen S., Murnion B., Cohen M., Ali R., Dunlop A., Holland R. Minimising the unintended consequences of opioid treatment: development of a drug behaviour scale for use in Australia. College on Problems of Drug Dependence 74th Annual Meeting 2012.
18. Nicholas M.K. The pain self-efficacy questionnaire: taking pain into account. Eur. J. Pain 2007, 11:153-163.
19. Nicholas M.K., Asghari A., Blyth F.M. What do the numbers mean? Normative data in chronic pain measures. Pain 2008, 134:158-173.
20. Nielsen S., Degenhardt L., Hoban B., Gisev N. Comparing opioids: a guide to estimating oral morphine equivalents (OME) in research. NDARC Technical Report No. 329 2014, National Drug and Alcohol Research Centre, UNSW, Australia.
21. Noble M., Treadwell J.R., Tregear S.J., Coates V.H., Wiffen P.J., Akafomo C., Schoelles K.M. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst. Rev. 2010, 1:CD006605.
22. Norberg M.M., Mackenzie J., Copeland J. Quantifying cannabis use with the Timeline Followback approach: a psychometric evaluation. Drug Alcohol Depend. 2012, 121:247-252.
23. Ogborne A.C., Smart R.G., Adlaf E.M. Self-reported medical use of marijuana: a survey of the general population. CMAJ 2000, 162:1685-1686.
24. Robson P.J. Therapeutic potential of cannabinoid medicines. Drug Test. Anal. 2014, 6:24-30.
25. Savage S.R. Opioid therapy of chronic pain: assessment of consequences. Acta Anaesthesiol. Scand. 1999, 43:909-917.
26. Spitzer R.L., Kroenke K., Williams J.B.W., Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 2006, 166:1092-1097.
27. Tan G., Jensen M.P., Thornby J.I., Shanti B.F. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J. Pain 2004, 5:133-137.
28. Therapeutic Goods Administration Standard for the Uniform Scheduling of Medicines and Poisons (SUSMP) 2013, Australian Government Department of Health and Ageing, http://wwwtgagovau/industry/scheduling-poisons-standardhtm (accessed 05.09.14).
29. Turk D.C., Dworkin R.H., Allen R.R., Bellamy N., Brandenburg N., Carr D.B., Cleeland C., Dionne R., Farrar J.T., Galer B.S., Hewitt D.J., Jadad A.R., Katz N.P., Kramer L.D., Manning D.C., McCormick C.G., McDermott M.P., McGrath P., Quessy S., Rappaport B.A., Robinson J.P., Royal M.A., Simon L., Stauffer J.W., Stein W., Tollett J., Witter J. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003, 106:337-345.
30. Vos T., Flaxman A.D., Naghavi M., Lozano R., Michaud C., Ezzati M., Shibuya K., Salomon J.A., Abdalla S., Aboyans V., Abraham J., Ackerman I., Aggarwal R., Ahn S.Y., Ali M.K., Alvarado M., Anderson H.R., Anderson L.M., Andrews K.G., Atkinson C., Baddour L.M., Bahalim A.N., Barker-Collo S., Barrero L.H., Bartels D.H., Basanez M.G., Baxter A., Bell M.L., Benjamin E.J., Bennett D., Bernabe E., Bhalla K., Bhandari B., Bikbov B., Bin Abdulhak A., Birbeck G., Black J.A., Blencowe H., Blore J.D., Blyth F., Bolliger I., Bonaventure A., Boufous S.A., Bourne R., Boussinesq M., Braithwaite T., Brayne C., Bridgett L., Brooker S., Brooks P., Brugha T.S., Bryan-Hancock C., Bucello C., Buchbinder R., Buckle G.R., Budke C.M., Burch M., Burney P., Burstein R., Calabria B., Campbell B., Canter C.E., Carabin H., Carapetis J., Carmona L., Cella C., Charlson F., Chen H.L., Cheng A.T.A., Chou D., Chugh S.S., Coffeng L.E., Colan S.D., Colquhoun S., Colson K.E., Condon J., Connor M.D., Cooper L.T., Corriere M., Cortinovis M., de Vaccaro K.C., Couser W., Cowie B.C., Criqui M.H., Cross M., Dabhadkar K.C., Dahiya M., Dahodwala N., Damsere-Derry J., Danaei G., Davis A., De Leo D., Degenhardt L., Dellavalle R., Delossantos A., Denenberg J., Derrett S., Des Jarlais D.C., Dharmaratne S.D., Dherani M., Diaz-Torne C., Dolk H., Dorsey E.R., Driscoll T., Duber H., Ebel B., Edmond K., Elbaz A., Ali S.E., Erskine H., Erwin P.J., Espindola P., Ewoigbokhan S.E., Farzadfar F., Feigin V., Felson D.T., Ferrari A., Ferri C.P., Fevre E.M., Finucane M.M., Flaxman S., Flood L., Foreman K., Forouzanfar M.H., Fowkes F.G.R., Franklin R., Fransen M., Freeman M.K., Gabbe B.J., Gabriel S.E., Gakidou E., Ganatra H.A., Garcia B., Gaspari F., Gillum R.F., Gmel G., Gosselin R., Grainger R., Groeger J., Guillemin F., Gunnell D., Gupta R., Haagsma J., Hagan H., Halasa Y.A., Hall W., Haring D., Haro J.M., Harrison J.E., Havmoeller R., Hay R.J., Higashi H., Hill C., Hoen B., Hoffman H., Hotez P.J., Hoy D., Huang J.J., Ibeanusi S.E., Jacobsen K.H., James S.L., Jarvis D., Jasrasaria R., Jayaraman S., Johns N., Jonas J.B., Karthikeyan G., Kassebaum N., Kawakami N., Keren A., Khoo J.P., King C.H., Knowlton L.M., Kobusingye O., Koranteng A., Krishnamurthi R., Lalloo R., Laslett L.L., Lathlean T., Leasher J.L., Lee Y.Y., Leigh J., Lim S.S., Limb E., Lin J.K., Lipnick M., Lipshultz S.E., Liu W., Loane M., Ohno S.L., Lyons R., Ma J.X., Mabweijano J., MacIntyre M.F., Malekzadeh R., Mallinger L., Manivannan S., Marcenes W., March L., Margolis D.J., Marks G.B., Marks R., Matsumori A., Matzopoulos R., Mayosi B.M., McAnulty J.H., McDermott M.M., McGill N., McGrath J., Medina-Mora M.E., Meltzer M., Mensah G.A., Merriman T.R., Meyer A.C., Miglioli V., Miller M., Miller T.R., Mitchell P.B., Mocumbi A.O., Moffitt T.E., Mokdad A.A., Monasta L., Montico M., Moradi-Lakeh M., Moran A., Morawska L., Mori R., Murdoch M.E., Mwaniki M.K., Naidoo K., Nair M.N., Naldi L., Narayan K.M.V., Nelson P.K., Nelson R.G., Nevitt M.C., Newton C.R., Nolte S., Norman P., Norman R., O'Donnell M., O'Hanlon S., Olives C., Omer S.B., Ortblad K., Osborne R., Ozgediz D., Page A., Pahari B., Pandian J.D., Rivero A.P., Patten S.B., Pearce N., Padilla R.P., Perez-Ruiz F., Perico N., Pesudovs K., Phillips D., Phillips M.R., Pierce K., Pion S., Polanczyk G.V., Polinder S., Pope C.A., Popova S., Porrini E., Pourmalek F., Prince M., Pullan R.L., Ramaiah K.D., Ranganathan D., Razavi H., Regan M., Rehm J.T., Rein D.B., Remuzzi G., Richardson K., Rivara F.P., Roberts T., Robinson C., De Leon F.R., Ronfani L., Room R., Rosenfeld L.C., Rushton L., Sacco R.L., Saha S., Sampson U., Sanchez-Riera L., Sanman E., Schwebel D.C., Scott J.G., Segui-Gomez M., Shahraz S., Shepard D.S., Shin H., Shivakoti R., Singh D., Singh G.M., Singh J.A., Singleton J., Sleet D.A., Sliwa K., Smith E., Smith J.L., Stapelberg N.J.C., Steer A., Steiner T., Stolk W.A., Stovner L.J., Sudfeld C., Syed S., Tamburlini G., Tavakkoli M., Taylor H.R., Taylor J.A., Taylor W.J., Thomas B., Thomson W.M., Thurston G.D., Tleyjeh I.M., Tonelli M., Towbin J.R.A., Truelsen T., Tsilimbaris M.K., Ubeda C., Undurraga E.A., van der Werf M.J., van Os J., Vavilala M.S., Venketasubramanian N., Wang M.R., Wang W.Z., Watt K., Weatherall D.J., Weinstock M.A., Weintraub R., Weisskopf M.G., Weissman M.M., White R.A., Whiteford H., Wiersma S.T., Wilkinson J.D., Williams H.C., Williams S.R.M., Witt E., Wolfe F., Woolf A.D., Wulf S., Yeh P.H., Zaidi A.K.M., Zheng Z.J., Zonies D., Lopez A.D., Murray C.J.L. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2163-2196.
31. Ware M.A., Doyle C.R., Woods R., Lynch M.E., Clark A.J. Cannabis use for chronic non-cancer pain: results of a prospective survey. Pain 2003, 102:211-216.
32. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders - Diagnostic Criteria for Research 1993, World Health Organization, Geneva.